27 Mar 2024 Research and Development Spotlight Series – Episode 1 Blogs | Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics
06 Mar 2024 Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024 Therapeutics